Clinical Trials Directory

Trials / Unknown

UnknownNCT06021886

CS Scar Impact on ART Outcomes

Status
Unknown
Phase
Study type
Observational
Enrollment
510 (estimated)
Sponsor
HealthPlus Fertility Center · Academic / Other
Sex
Female
Age
25 Years – 40 Years
Healthy volunteers
Not accepted

Summary

CS scar impact on ART outcomes, Retrospective Cohort Study IVF outcome can be affected by the presence of caesarean section scar with or without defect in different ways

Detailed description

CS scar impact on ART outcomes, Retrospective Cohort Study IVF outcome can be affected by the presence of caesarean section scar with or without defect in different ways; increase difficulty of embryo transfer, presence intrauterine fluid at the time of transfer can affect the chances of embryo implantation and increase the rate of spontaneous miscarriages To compare the success rates and outcomes of pregnancies of frozen embryo transfer for euploid embryos in patients without caesarean section, and who had caesarean section (with or without a NICHE) after euploid embryo transfer. Does CS scar and CS scar defect affect IVF outcome? All women who underwent an embryo transfer with a Euploid embryo between 2015 and 2022, who meet the inclusion criteria will be included in the study. * Inclusion Criteria: Age 25-40 years old. Euploid embryo transfer. Medically free BMI less tha 30 kg/m2 Hormone therapy preparation for FET. * Exclusion criteria Previous uterine scar other than cesarean section. Congenital uterine abnormalities Presence of intrauterine lesions e.g., polyp, fibroid, Endometriosis or adenomyosis Hydrosalpinx, Chronic endometritis * Primary outcome: Clinical pregnancy rate, defined as a pregnancy with a detectable heart rate at 7 weeks of gestation or beyond. * Secondary outcomes : Early pregnancy complications Ectopic pregnancy or Miscarriage. Caesarean section scar dehiscence or

Conditions

Timeline

Start date
2023-06-15
Primary completion
2024-01-01
Completion
2024-01-01
First posted
2023-09-01
Last updated
2023-11-21

Locations

1 site across 1 country: United Arab Emirates

Source: ClinicalTrials.gov record NCT06021886. Inclusion in this directory is not an endorsement.